Share on StockTwits

MedAssets (NASDAQ:MDAS) has earned a consensus rating of “Hold” from the twenty-three analysts that are presently covering the stock, Stock Ratings Network.com reports. Twelve equities research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $25.40.

MedAssets (NASDAQ:MDAS) opened at 21.10 on Friday. MedAssets has a 52-week low of $19.38 and a 52-week high of $26.58. The stock’s 50-day moving average is $23.08 and its 200-day moving average is $23.21. The company has a market cap of $1.268 billion and a price-to-earnings ratio of 44.87.

MedAssets (NASDAQ:MDAS) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.29 by $0.01. The company had revenue of $175.42 million for the quarter, compared to the consensus estimate of $175.70 million. During the same quarter last year, the company posted $0.30 earnings per share. MedAssets’s revenue was up 2.7% compared to the same quarter last year. Analysts expect that MedAssets will post $1.35 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Raymond James reiterated an “outperform” rating on shares of MedAssets in a research note on Thursday, July 31st. They now have a $27.50 price target on the stock, up previously from $25.00. Separately, analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Finally, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.